dual antiplatelet therapy
Showing 1 - 11 of 11
Acute Coronary Syndrome, Percutaneous Coronary Intervention, Dual Antiplatelet Therapy Trial in Wonju (Genoss DES™ stent)
Recruiting
- Acute Coronary Syndrome
- +2 more
- Genoss DES™ stent
-
Wonju, Gangwon State, Korea, Republic ofWonju Severance Christian Hospital
Oct 4, 2023
Coronary Artery Disease, Percutaneous Coronary Intervention, Dual Antiplatelet Therapy Trial in Wonju (Genoss DES™ stent)
Recruiting
- Coronary Artery Disease
- +2 more
- Genoss DES™ stent
-
Wŏnju, Gangwon State, Korea, Republic ofWonju Severance Christian Hospital
Oct 4, 2023
Elevated Lipoprotein(a) Level, Coronary Artery Disease, Drug-Eluting Stent Trial in Beijing (24 Months DAPT, 12 Months DAPT)
Not yet recruiting
- Elevated Lipoprotein(a) Level
- +3 more
- 24 Months DAPT
- 12 Months DAPT
-
Beijing, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, Chi
Aug 26, 2023
Dual Antiplatelet Therapy, Acute Coronary Syndrome, Coronary Artery Disease Trial in Messina, Rivoli (P2Y12 inhibitor
Not yet recruiting
- Dual Antiplatelet Therapy
- +2 more
- P2Y12 inhibitor de-escalation
-
Messina, Italy
- +1 more
Jun 12, 2023
Coronary Artery Disease, Coronary Artery Bypass Grafting, Dual Antiplatelet Therapy Trial in Beijing (De-escalated Dual
Recruiting
- Coronary Artery Disease
- +6 more
- De-escalated Dual Antiplatelet Therapy
- Dual Antiplatelet Therapy
-
Beijing, ChinaFuwai Hospital
Dec 13, 2022
ST Elevated Myocardial Infarction, Dual Antiplatelet Therapy Trial in Dordrecht, Rotterdam (Prasugrel based short DAPT,
Recruiting
- ST Elevated Myocardial Infarction
- Dual Antiplatelet Therapy
- Prasugrel based short DAPT
- +3 more
-
Dordrecht, Netherlands
- +2 more
Aug 5, 2022
Coronary Disease, Drug Eluting Stent, Percutaneous Coronary Intervention Trial in Shenyang (1 month DAPT, 6 months DAPT)
Recruiting
- Coronary Disease
- +3 more
- 1 month DAPT
- 6 months DAPT
-
Shenyang, Liaoning, ChinaThe General Hospital of Shenyang Military
Sep 8, 2020
Coronary Artery Disease, Percutaneous Coronary Intervention, Dual Antiplatelet Therapy Trial in Seoul (prolonged DAPT)
Unknown status
- Coronary Artery Disease
- +2 more
- prolonged DAPT
-
Seoul, Korea, Republic ofSeoul National University Hospital
Feb 20, 2018
Platelet Reactivity Following Cessation of Dual Antiplatelet
Unknown status
- Dual Antiplatelet Therapy
- Platelet Reactivity
- Platelet reactivity testing
-
Petach-Tikva, IsraelRabin Medical Center - Hsharon Campus
Jun 17, 2016
Patients Undergoing Percutaneous Coronary Intervention Through
Completed
- Percutaneous Coronary Intervention
- +3 more
-
New York, New YorkMount Sinai Medical Center
Dec 22, 2015